Cassaday & Co Wealth Management LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,779 shares of the financial services provider’s stock, valued at approximately $229,000.
A number of other large investors also recently added to or reduced their stakes in MET. Quest Partners LLC boosted its holdings in MetLife by 299,333.3% during the 3rd quarter. Quest Partners LLC now owns 8,983 shares of the financial services provider’s stock valued at $741,000 after acquiring an additional 8,980 shares during the period. TrinityPoint Wealth LLC purchased a new position in MetLife in the 3rd quarter valued at approximately $237,000. Claro Advisors LLC grew its stake in shares of MetLife by 2.3% in the third quarter. Claro Advisors LLC now owns 13,483 shares of the financial services provider’s stock worth $1,112,000 after acquiring an additional 308 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife in the third quarter valued at $30,000. Finally, River Street Advisors LLC boosted its holdings in MetLife by 2.8% in the third quarter. River Street Advisors LLC now owns 18,585 shares of the financial services provider’s stock valued at $1,533,000 after purchasing an additional 513 shares during the period. 89.81% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the company. Morgan Stanley reduced their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Barclays decreased their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Piper Sandler lifted their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Bank of America dropped their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Fourteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $88.46.
MetLife Stock Up 0.0 %
Shares of NYSE:MET opened at $83.37 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $57.73 billion, a P/E ratio of 16.81, a P/E/G ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 1-year low of $61.85 and a 1-year high of $86.94. The firm has a fifty day moving average price of $81.76 and a 200 day moving average price of $75.71.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.61%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- What are earnings reports?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Calculate Inflation Rate
- Applied Materials Market Capitulates: Now is the Time to Buy
- Following Congress Stock Trades
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.